Advertisement
Screener

Celldex Therapeutics, Inc. (CLDX) ROE

Celldex Therapeutics, Inc. (CLDX) ROE

  • 2026-06-30: ROE -42.06%.
  • 2026-03-31: ROE -62.17%.
  • 2025-12-31: ROE -49.08%.
  • 2025-09-30: ROE -37.52%.

Complete source-backed roe history.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-30-42.06%
2026-03-31-62.17%
2025-12-31-49.08%
2025-09-30-37.52%
2025-06-30-30.46%
2025-03-31-25.44%
2024-12-31-21.13%
2024-09-30-15.40%
2024-06-30-10.87%

Annual ROE

DateROE
2025-12-31-49.08%
2024-12-31-21.13%
2023-12-31-32.95%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93